|
|
|
Insider
Information: |
Sinha Vikas |
Relationship: |
|
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,308,459 |
|
Indirect Shares
|
16,674,766 |
|
|
Direct
Value |
$33,419,819 |
|
|
Indirect Value
|
$12,547,761 |
|
|
Total
Shares |
17,983,225 |
|
|
Total
Value |
$45,967,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
23
|
Stock
price went up :
|
0
|
8
|
Stock
price went down : |
0
|
15
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-725.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
|
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
32,706 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
167,808 |
0 |
- |
|
ALVR |
Allovir Inc |
See Remarks |
|
2023-01-19 |
4 |
AS |
$5.08 |
$25,952 |
D/D |
(5,111) |
1,031,664 |
0 |
% |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-12-18 |
4 |
AS |
$182.08 |
$1,000,165 |
D/D |
(5,493) |
157,277 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-11-06 |
4 |
OE |
$17.98 |
$102,360 |
D/D |
5,693 |
168,463 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-11-06 |
4 |
AS |
$195.00 |
$1,110,135 |
D/D |
(5,693) |
162,770 |
0 |
- |
|
ALVR |
Allovir Inc |
See Remarks |
|
2022-01-20 |
4 |
S |
$8.75 |
$56,454 |
D/D |
(6,450) |
858,957 |
0 |
% |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP, CFO |
|
2011-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
81,478 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
|
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
66,197 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
54,307 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
179,862 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
139,520 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
|
2008-08-01 |
4 |
OE |
$27.58 |
$275,800 |
D/D |
10,000 |
41,149 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
|
2008-08-01 |
4 |
AS |
$92.28 |
$923,520 |
D/D |
(10,000) |
31,149 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2009-12-10 |
4 |
S |
$46.00 |
$460,000 |
D/D |
(10,000) |
49,707 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-04-01 |
4 |
AS |
$100.00 |
$1,000,000 |
D/D |
(10,000) |
86,480 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-04-01 |
4 |
OE |
$13.79 |
$137,900 |
D/D |
10,000 |
96,480 |
0 |
- |
|
ALVR |
Allovir Inc |
See Remarks |
|
2023-08-17 |
4 |
S |
$2.50 |
$26,243 |
D/D |
(10,516) |
1,173,701 |
0 |
% |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,690 |
167,396 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,763 |
177,706 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-09-15 |
4 |
OE |
$16.35 |
$196,200 |
D/D |
12,000 |
65,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-07-13 |
4 |
AS |
$52.53 |
$765,152 |
D/D |
(14,566) |
352,974 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-07-13 |
4 |
OE |
$6.90 |
$100,505 |
D/D |
14,566 |
367,540 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-12-09 |
4 |
AS |
$127.66 |
$2,294,561 |
D/D |
(17,974) |
134,321 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-12-09 |
4 |
OE |
$17.65 |
$317,241 |
D/D |
17,974 |
152,295 |
0 |
- |
|
145 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|